Unknown PHASE1 INTERVENTIONAL 1-arm NCT01764100

Mesenchymal Stromal Cells (MSCs) for the Treatment of Graft Versus Host Disease (GVHD) (MSC-GvHD)

Mesenchymal Stromal Cells (MSC) for the Treatment of Severe (Grade II-IV) Steroid-resistant Graft Versus Host Disease (GVHD): a Phase I Trial

Sponsor: Ettore Biagi, MD

Conditions Graft vs Host Disease

Interventions Mesenchymal stromal cells

Updated 5 times since 2017 Last updated: Jan 7, 2013 Started: Sep 30, 2009 Primary completion: May 31, 2013 Completion: Sep 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Graft vs Host Disease, this trial is ongoing. The trial is conducted by Ettore Biagi, MD and has accumulated 5 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE1
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE1

First recorded

Sep 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ettore Biagi, MD

Data source: Azienda Ospedaliera San Gerardo di Monza

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bergamo, Italy
• Monza, Italy